Diligence memo · auto-generated · as of July 2, 2026
Senzime AB (publ)
Senzime AB (publ) looks under-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Senzime AB (publ) operates in Other Health Care, based in UPPSALA.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Senzime AB (publ) has raised $7.4M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $7.1M on 2016-05-17.
Most recent recorded round closed around 2017-03-27.
Valuation (modeled)modeled
Provath models Senzime AB (publ) at approximately $6.2M (range $397K–$34M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.05× the median modeled value of Series A Other Health Care companies in 2016–2018 (157 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 10 months.
Last raise 9.3 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round was 23.0× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 71% of Other Health Care peers (5377 compared).
Modeled value ranks above 26% of those peers.
Closest niche peers: HemoSonics, LLC, Airxpanders Inc, Mercator Medsystems Inc, Simple Contacts Inc., AVG Holdings, Inc..
Peoplefiled
6 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.